TABLE 1.
Patients' clinicopathologic findings.
| Patient characteristics | n = 53 |
|---|---|
| Age, year | 71 (63–76) |
| Sex, n (%) | |
| Male | 28 (52.8) |
| Female | 25 (47.2) |
| CA 19‐9, U/mL | 129 (16–460.7) |
| CEA, ng/mL | 3.6 (2.0–6.2) |
| Primary tumor location, n (%) | |
| Head | 33 (62.3) |
| Body/Tail | 20 (37.7) |
| Pancreatectomy, n (%) | |
| Pancreaticoduodenectomy | 30 (56.6) |
| Distal pancreatectomy | 20 (37.7) |
| Total pancreatectomy | 3 (5.7) |
| T category, T3/4, n (%) | 45 (84.9) |
| Nodal disease, n (%) | 36 (67.9) |
| Histological differentiation, n (%) | |
| Well differentiated | 6 (11.3) |
| Moderately/Poorly differentiated | 47 (88.7) |
| Stage, n (%) | |
| IA/IB | 4 (7.6) |
| IIA | 12 (22.6) |
| IIB | 34 (64.2) |
| III | 1 (1.9) |
| IV | 2 (3.8) |
| R0 resection, n (%) | 51 (96.2) |
| Clavien−Dindo classification ≥IIIa, n (%) | 15 (28.3) |
| Postoperative pancreatic fistula (grade B/C), n (%) | 11 (20.8) |
| Length of hospital stay (days) | 33 (31–37) |
Abbreviations: CA 19‐9, carbohydrate antigen 19‐9, CEA, carcinoembryonic antigen.